Fan G,Wu X-G,Jiao W-P,Zhang H-K D-L .2022 .Safety and efficacy of intracoronary recombinant human prourokinase administration in patients with acute myocardial infarction and ST?segment elevation: A meta-analysis of randomized controlled trials. Exp Ther Med, 25 : 40.
Annibali G,Scrocca I,Aranzulla TC,Meliga E,Maiellaro F,Musumeci G .2022 ."No-Reflow" Phenomenon: A Contemporary Review. J Clin Med, 11 : 2233.
Khan MA,Samiullah JR,Shaikh JK,Butt MH,Hassan MU .2023 .Renal Dysfunction as a Predictor of Slow-Flow/No-Reflow Phenomenon and Impaired ST-Segment Resolution after Percutaneous Coronary Intervention in ST- Elevation Myocardial Infarction. A Retrospective Analysis. Pakistan J Med Heal Sci, 17 : 557-61.
Savic L,Mrdovic I,Asanin M,Lasica R,Krljanac G,Rajic D .2023 .The impact of kidney function on the slow-flow/no-reflow phenomenon in patients treated with primary percutaneous coronary intervention: registry analysis. Eur Hear J Acute Cardiovasc Care, 12 : .
Kumar R,Qayyum D,Ahmed I,Rai L,Mir A,Awan R,Cardiol J Interv .2023 .Predilation Ballooning in High Thrombus Laden STEMIs: An Independent Predictor of Slow Flow/No-Reflow in Patients Undergoing Emergent Percutaneous Coronary Revascularization. , : 1-6.
Søndergaard FT,Beske RP,Frydland M,Møller JE,Helgestad OKL,Jensen LO .2023 .Soluble ST2 in plasma is associated with postprocedural no-or-slow reflow after primary percutaneous coronary intervention in ST-elevation myocardial infarction. Eur Hear Journal Acute Cardiovasc Care, 12 : 48-52.
Singh R,Singla S,Singla A,Manchanda S,Kaur M. .2022 .Management of no reflow during percutaneous transcoronary angioplasty with catheter-directed intracoronary thrombolysis: A retrospective observational study. Int J Appl Basic Med Res, 12 : 260.
Xu B,Zhang C,Wei W,Zhan Y,Yang M,Wang Y .2023 .Effect of optimized thrombus aspiration on myocardial perfusion and prognosis in acute ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention. Front Cardiovasc Med, 10 : 1249924.
Gomez‐Lara J,Gracida M,Rivero F,Gutiérrez‐Barrios A,Muntané‐ Carol G,Romaguera R .2023 .Treatment of Slow‐Flow After Primary Percutaneous Coronary Intervention With FlowMediated Hyperemia: The Randomized RAIN‐FLOW Study. J Am Heart Assoc, 12(13) : e030285.
Grancini L,Diana D,Centola A,Monizzi G,Mastrangelo A,Olivares P .2023 .The SALINE Technique for the Treatment of the NoReflow Phenomenon during Percutaneous Coronary Intervention in STEMI. J Clin Med, 12 : 2405.
Gupta H,Parihar S,Tripathi VD .2022 .Assessment of the Efficacy and Safety of Early Intracoronary Nicorandil Administration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. , 14(5) : e25349.
Babapoor B,Sadeghieh-Ahari S,Sadeghi Hariri M,Shahbazzadegan B .2022 .Survey of effective factors in slow flow and no reflow in primary percutaneous coronary intervention patients. Int J Community Med Public Heal, 9 : 1222.
Godinez Cordova LB,Gonzalez-Pacheco H,Gopar-Nieto R,Eid-Lidt G,Briseno-De La Cruz JL,Araiza-Garaygordobil D .2022 .Prevalence and prognostic implications of the no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention in a university center in a middle-income country. Eur Heart J, 43(Supplement) : ehac544-2066.
Darwish A,Frere A-F,Abdelsamie M,Awady W El .2022 .Intracoronary epinephrine versus adenosine in the management of refractory no-reflow phenomenon: a single-center retrospective cohort study. Ann Saudi Med, 42 : 75-82.